Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies.

Lord, Phillip; Spiering, Rachel; Aguillon, Juan C; Anderson, Amy E; Appel, Silke; Benitez-Ribas, Daniel; Ten Brinke, Anja; Broere, Femke; Cools, Nathalie; Cuturi, Maria Cristina; Diboll, Julie; Geissler, Edward K; Giannoukakis, Nick; Gregori, Silvia; van Ham, S Marieke; Lattimer, Staci; Marshall, Lindsay; Harry, Rachel A; Hutchinson, James A; Isaacs, John D; Joosten, Irma; van Kooten, Cees; Lopez Diaz de Cerio, Ascension; Nikolic, Tatjana; Oral, Haluk Barbaros; Sofronic-Milosavljevic, Ljiljana; Ritter, Thomas; Riquelme, Paloma; Thomson, Angus W; Trucco, Massimo; Vives-Pi, Marta; Martinez-Caceres, Eva M; Hilkens, Catharien M U

Lord, Phillip; Spiering, Rachel; Aguillon, Juan C; Anderson, Amy E; Appel, Silke; Benitez-Ribas, Daniel; Ten Brinke, Anja; Broere, Femke; Cools, Nathalie; Cuturi, Maria Cristina; Diboll, Julie; Geissler, Edward K; Giannoukakis, Nick; Gregori, Silvia; van Ham, S Marieke; Lattimer, Staci; Marshall, Lindsay; Harry, Rachel A; Hutchinson, James A; Isaacs, John D; Joosten, Irma; van Kooten, Cees; Lopez Diaz de Cerio, Ascension; Nikolic, Tatjana; Oral, Haluk Barbaros; Sofronic-Milosavljevic, Ljiljana; Ritter, Thomas; Riquelme, Paloma; Thomson, Angus W; Trucco, Massimo; Vives-Pi, Marta; Martinez-Caceres, Eva M; Hilkens, Catharien M U.

Afiliación

Lord P; School of Computing Science, Newcastle University, Newcastle upon Tyne, United Kingdom.
Spiering R; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Aguillon JC; Instituto de Ciencias Biomédicas (ICBM), Universidad de Chile, Santiago, Chile.
Anderson AE; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Appel S; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
Benitez-Ribas D; Department of Immunology, Hospital Clínic i Provincial and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.
Ten Brinke A; Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands.
Broere F; Faculty of Veterinary Medicine, Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands.
Cools N; Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
Cuturi MC; Center for Research in Transplantation and Immunology, ITUN, Inserm UMRS 1064, Nantes, France.
Diboll J; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Geissler EK; Department of Surgery, Section of Experimental Surgery, University Hospital Regensburg, Regensburg, Germany.
Giannoukakis N; Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States of America.
Gregori S; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Division of Regenerative Medicine, Stem Cells and Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy.
van Ham SM; Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands.
Lattimer S; School of Computing Science, Newcastle University, Newcastle upon Tyne, United Kingdom.
Marshall L; School of Computing Science, Newcastle University, Newcastle upon Tyne, United Kingdom.
Harry RA; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Hutchinson JA; Department of Surgery, Section of Experimental Surgery, University Hospital Regensburg, Regensburg, Germany.
Isaacs JD; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Joosten I; Department of Laboratory Medicine, Radboud University medical center, Nijmegen, The Netherlands.
van Kooten C; Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Lopez Diaz de Cerio A; Area of Cell Therapy, University Clinic of Navarra, Pamplona, Spain.
Nikolic T; Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
Oral HB; Department of Immunology, Faculty of Medicine, Uludag University, Bursa, Turkey.
Sofronic-Milosavljevic L; Institute for the Application of Nuclear Energy INEP, University of Belgrade, Belgrade, Serbia.
Ritter T; Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway, Ireland.
Riquelme P; Department of Surgery, Section of Experimental Surgery, University Hospital Regensburg, Regensburg, Germany.
Thomson AW; Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America.
Trucco M; Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, United States of America.
Vives-Pi M; Immunology Division, Germans Trias i Pujol University Hospital and Health Sciences Research Institute, Badalona, Spain.
Martinez-Caceres EM; CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Hilkens CMU; Immunology Division, Germans Trias i Pujol University Hospital and Health Sciences Research Institute, Badalona, Spain.

PeerJ ; 4: e2300, 2016.

Article en En | MEDLINE | ID: mdl-27635311

Palabras clave

Antigen-presenting cells; Autoimmune disease; Cell therapy; Minimum information model; Regulatory macrophages; Reporting guidelines; Tolerogenic dendritic cells; Transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google